Literature DB >> 31721088

Association of subclinical thyroid dysfunction with bone mineral density and fracture: a meta-analysis of prospective cohort studies.

Hongling Zhu1, Jichen Zhang1, Jingnan Wang1, Xuemei Zhao1, Mingjun Gu2.   

Abstract

PURPOSE: To comprehensively investigate the associations of subclinical thyroid dysfunction with BMD and fractures at various sites.
METHODS: Comprehensive electronic and manual searches of databases were systematically conducted to identify prospective cohort studies from the inception of the databases to May 2019. The summary results for fractures and BMDs at various sites were calculated by relative risks (RRs) and weighted mean differences (WMDs) with corresponding 95% confidence intervals (CIs) using the random-effects model.
RESULTS: Seventeen prospective cohorts from 24 studies were identified and 313,557 individuals were recruited in a final analysis. The summary RR indicated that subclinical hyperthyroidism was associated with an increased risk of any fracture (RR, 1.17; 95% CI, 1.08-1.26; P < 0.001), hip fracture (RR, 1.27; 95% CI, 1.09-1.48; P = 0.003), spine fracture (RR, 1.97; 95% CI, 1.31-2.97; P = 0.001), and non-spine fracture (RR, 1.19; 95% CI, 1.04-1.37; P = 0.014). However, there were no significant associations of subclinical hypothyroidism with the risk of any fractures (P = 0.166), hip fracture (P = 0.068), spine fracture (P = 0.818), and non-spine fracture (P = 0.277). Finally, subclinical hyperthyroidism was associated with lower distal forearm BMD in women, and ultradistal forearm BMD in both men and women, whereas subclinical hypothyroidism was associated with higher femur neck BMD in women.
CONCLUSION: Subclinical hyperthyroidism could induce additional risk on fractures at any, hip, spine, and non-spine, whereas subclinical hypothyroidism did not have any impact on fractures. Moreover, BMD at the lower distal and ultradistal forearms might be affected by subclinical hyperthyroidism, and higher femur neck BMD could be affected by subclinical hypothyroidism.

Entities:  

Keywords:  Bone mineral density; Fracture; Meta-analysis; Subclinical thyroid dysfunction

Mesh:

Year:  2019        PMID: 31721088     DOI: 10.1007/s12020-019-02110-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts.

Authors:  Carole E Aubert; Carmen Floriani; Douglas C Bauer; Bruno R da Costa; Daniel Segna; Manuel R Blum; Tinh-Hai Collet; Howard A Fink; Anne R Cappola; Lamprini Syrogiannouli; Robin P Peeters; Bjørn O Åsvold; Wendy P J den Elzen; Robert N Luben; Alexandra P Bremner; Apostolos Gogakos; Richard Eastell; Patricia M Kearney; Mari Hoff; Erin Le Blanc; Graziano Ceresini; Fernando Rivadeneira; André G Uitterlinden; Kay-Tee Khaw; Arnulf Langhammer; David J Stott; Rudi G J Westendorp; Luigi Ferrucci; Graham R Williams; Jacobijn Gussekloo; John P Walsh; Drahomir Aujesky; Nicolas Rodondi
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

2.  Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.

Authors:  D Segna; D C Bauer; M Feller; C Schneider; H A Fink; C E Aubert; T-H Collet; B R da Costa; K Fischer; R P Peeters; A R Cappola; M R Blum; H A van Dorland; J Robbins; K Naylor; R Eastell; A G Uitterlinden; F Rivadeneira Ramirez; A Gogakos; J Gussekloo; G R Williams; A Schwartz; J A Cauley; D A Aujesky; H A Bischoff-Ferrari; N Rodondi
Journal:  J Intern Med       Date:  2017-10-16       Impact factor: 8.989

3.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

4.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

Review 5.  Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  Thyroid       Date:  2003-06       Impact factor: 6.568

6.  Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.

Authors:  Z Yan; H Huang; J Li; J Wang
Journal:  Osteoporos Int       Date:  2015-07-30       Impact factor: 4.507

Review 7.  Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis.

Authors:  Christina D Wirth; Manuel R Blum; Bruno R da Costa; Christine Baumgartner; Tinh-Hai Collet; Marco Medici; Robin P Peeters; Drahomir Aujesky; Douglas C Bauer; Nicolas Rodondi
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

8.  Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density.

Authors:  Gherardo Mazziotti; Teresa Porcelli; Ilaria Patelli; Pier Paolo Vescovi; Andrea Giustina
Journal:  Bone       Date:  2009-11-03       Impact factor: 4.398

9.  Subclinical thyroid dysfunction and fracture risk: a meta-analysis.

Authors:  Manuel R Blum; Douglas C Bauer; Tinh-Hai Collet; Howard A Fink; Anne R Cappola; Bruno R da Costa; Christina D Wirth; Robin P Peeters; Bjørn O Åsvold; Wendy P J den Elzen; Robert N Luben; Misa Imaizumi; Alexandra P Bremner; Apostolos Gogakos; Richard Eastell; Patricia M Kearney; Elsa S Strotmeyer; Erin R Wallace; Mari Hoff; Graziano Ceresini; Fernando Rivadeneira; André G Uitterlinden; David J Stott; Rudi G J Westendorp; Kay-Tee Khaw; Arnuf Langhammer; Luigi Ferrucci; Jacobijn Gussekloo; Graham R Williams; John P Walsh; Peter Jüni; Drahomir Aujesky; Nicolas Rodondi
Journal:  JAMA       Date:  2015-05-26       Impact factor: 56.272

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  6 in total

Review 1.  Secondary Osteoporosis and Metabolic Bone Diseases.

Authors:  Mahmoud M Sobh; Mohamed Abdalbary; Sherouk Elnagar; Eman Nagy; Nehal Elshabrawy; Mostafa Abdelsalam; Kamyar Asadipooya; Amr El-Husseini
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.964

2.  Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.

Authors:  B É C A Sousa; B C Silva; T de Oliveira Guidotti; M C Pires; M M S Soares; A M Kakehasi
Journal:  J Endocrinol Invest       Date:  2021-03-17       Impact factor: 4.256

3.  Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.

Authors:  Federico Hawkins Carranza; Sonsoles Guadalix Iglesias; María Luisa De Mingo Domínguez; Cristina Martín-Arriscado Arroba; Begoña López Álvarez; Gonzalo Allo Miguel; Guillermo Martínez Díaz-Guerra
Journal:  Cancer Med       Date:  2020-06-25       Impact factor: 4.452

4.  Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.

Authors:  C Vendrami; P Marques-Vidal; E Gonzalez Rodriguez; D Hans; G Waeber; O Lamy
Journal:  Osteoporos Int       Date:  2021-08-19       Impact factor: 4.507

5.  Bone metabolism is a key factor for clinical outcome of tibial plateau fractures.

Authors:  Matthias Krause; Lena Alm; Markus Berninger; Christoph Domnick; Kai Fehske; Karl-Heinz Frosch; Elmar Herbst; Alexander Korthaus; Michael Raschke; Reinhard Hoffmann
Journal:  Eur J Trauma Emerg Surg       Date:  2020-11-05       Impact factor: 3.693

6.  Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men.

Authors:  J Svensson; C Ohlsson; M K Karlsson; M Lorentzon; C Lewerin; D Mellström
Journal:  Osteoporos Int       Date:  2021-05-19       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.